Field Guide · Deconstructed

Low-Dose Naltrexone.
Calming an immune system stuck in over-reaction.

For a lot of PANS and mold kids the immune system isn’t weak — it’s stuck in the on position, mis-firing against the child’s own brain. This entry sits in one of Jill Crista’s four cores, “regulate immunity” — the quiet work of teaching an over-reactive immune system to stand down. The most interesting tool there is LDN: a tiny dose of an old opioid-blocker that, counterintuitively, calms neuroinflammation and rebalances the immune tilt. Here are the facts: what it actually is, why it fits these kids, the honest evidence, and how it’s dosed. Choose your own adventure from here.

I walked this part of the labyrinth myself — knocked on the doors, read the research, and came back with the map. You don’t have to find the way out alone.

What this targets

This addresses immune dysregulation and neuroinflammation — the core problem in PANS and in mold-affected kids, where the immune system is over-reacting and the brain’s own immune cells (microglia) are inflamed. It’s the heart of Jill Crista’s “regulate immunity” core — not killing a bug, not draining a toxin, but retuning an immune system that’s stuck on high alert. LDN is the standout tool here because it works on both levers at once: it calms inflamed microglia in the brain and shifts the body’s inflammatory immune tilt back toward balance — without suppressing immunity. The honest caveat: the mechanism and the use in autoimmune disease are well-described, but in PANS specifically the evidence is clinical and emerging, not proven by trials. Sources: LDN — review of therapeutic utilization (Front. Med. 2018) · naltrexone modulates microglia (Int. J. Mol. Sci. 2021).

Crista’s four cores — where this sits

Naturopath Jill Crista, ND (author of Break the Mold) teaches a four-part framework for healing the mold-and-PANS child. LDN lives in the third core:

CoreThe work
Tame the flameCalm the inflammation already burning — the fire in the brain and body.
Beat the bugsClear the infections and mold driving the immune reaction.
Regulate immunity
← LDN lives here
Retune an immune system stuck in over-reaction — not suppress it, rebalance it. Crista’s toolkit here includes vitamin D3, peptides, postbiotics, and other immune modulators. LDN is a powerful addition to this core.
Guard the gatesWatch every portal for new infection — throat, teeth, gut, mold exposure, tick protection.

The point of “regulate immunity” is that for many of these kids, killing the bug isn’t enough — the immune system has learned to over-react, and it keeps reacting even after the trigger is handled. That learned over-reaction is what you’re calming here. Source: Dr. Jill Crista on a healing plan for PANDAS / PANS (four cores) · drcrista.com.

LDN — what it actually is

Here’s the part that surprises families. Naltrexone is an opioid-blocker — at its normal dose (about 50 mg) it’s used to block the high from opioids and alcohol. Low-dose naltrexone (LDN) is a tiny fraction of that — roughly 0.5 to 4.5 mg — and at that dose it does something completely different. It stops being an addiction drug and becomes an immune modulator and an anti-inflammatory.

How it works — in plain language

Two mechanisms, working together:

  • The endorphin rebound. At a tiny dose, naltrexone briefly blocks the body’s opioid receptors — only for a few hours. The body reads that brief block as “we’re running low” and responds by ramping up its own production of endorphins and enkephalins. Those natural opioids aren’t just about feeling good — they modulate and rebalance the immune system, nudging an over-active inflammatory tilt back toward calm. The block is gone by morning; the endorphin rise is what stays.
  • Calming the brain’s immune cells. Separately, LDN acts on a receptor called TLR4 on microglia — the immune cells of the brain. When microglia are stuck “on,” they pump out inflammatory signals (TNF-alpha, IL-1β, IL-6) that drive neuroinflammation. LDN quiets that microglial activation — directly calming the brain inflammation that PANS and mold kids carry.

The net effect is anti-inflammatory and immune-modulating — not immune-suppressing. It doesn’t blunt the child’s defenses; it teaches an over-reactive system to stand down. That’s exactly the fit for a kid whose immune system is mis-firing at their own brain. Sources: LDN review — endorphin rebound & glial TLR4 mechanism · naltrexone modulates microglia & inflammatory cytokines.

One honest footnote on mechanism: not every piece of the endorphin story is settled. At least one study found LDN’s benefits may run independent of the classic β-endorphin pathway — the glial / TLR4 anti-inflammatory action may be doing more of the work than the endorphin rebound. The effect is real and reproducible; the exact wiring is still being mapped. Source: benefits may be independent of the β-endorphin system (eNeuro 2021).

The honest evidence

This is the part most websites skip. Be clear-eyed about what’s proven and what isn’t:

Strong elsewhere, emerging in PANS

  • Real trial data — in other conditions. Small, blinded, randomized trials show LDN (around 4–4.5 mg nightly) improves pain in fibromyalgia, gastrointestinal symptoms in Crohn’s disease, and quality of life in multiple sclerosis. It also has growing evidence in long COVID, CRPS, and ME/CFS. These are autoimmune and immune-dysregulated conditions — the same family of problem as PANS.
  • Well-tolerated in kids. An 8-week pediatric trial in children with Crohn’s disease found LDN reduced disease severity without serious adverse events — useful safety reassurance for the pediatric population.
  • For pediatric PANS specifically, it’s clinical and emerging — not RCT-proven. There is no large controlled PANS/PANDAS trial. The use is built on the mechanism (immune modulation + calming neuroinflammation), the strong autoimmune track record, and growing clinical experience among PANS practitioners. So it’s a reasonable, low-risk tool to trial — not a guaranteed cure, and not a replacement for antibiotics or IVIG when those are indicated.

Sources: LDN review — fibromyalgia / Crohn’s / MS trial evidence · LDN for PANS/PANDAS — no large trials, used as part of a plan · LDN Research Trust — PANDAS.

The practical picture

If a family is going to trial LDN, here’s what it actually looks like. None of this is something to do alone — it needs a prescriber who is willing and experienced with LDN.

1IT’S A PRESCRIPTION — AND IT’S COMPOUNDED. Naltrexone is only sold commercially as a 50 mg tablet, so the low dose has to be made by a compounding pharmacy — as a measured liquid or capsule. A flavored liquid is the usual choice for a child who can’t swallow capsules and makes the tiny, increasing doses easy to measure. It’s generally inexpensive.

2START VERY LOW, TITRATE SLOWLY. Pediatric dosing starts at a small fraction of a milligram (often weight-based, e.g. ~0.1 mg/kg) and increases gradually over weeks toward a target usually at or below 4.5 mg/day. Low and slow is the whole game — it minimizes early side effects and lets you read tolerance.

3USUALLY AT BEDTIME. LDN is typically taken at night. The body makes most of its endorphins in the small hours of the morning, and bedtime dosing lines the brief receptor block up with that natural rhythm — so the rebound lands when the body is already ramping up. (Some kids who get vivid dreams do better moving the dose to morning — a prescriber can adjust.)

4HONEST EARLY SIDE EFFECTS. The most common are vivid dreams and changes in sleep, sometimes mild agitation or a headache in the first stretch — and these usually settle as the body adjusts or with a small dose/timing tweak. It’s well-tolerated overall, and because it’s low-dose and not habit-forming, it can simply be stopped. Sources: pediatric LDN — compounded liquid, weight-based start, mild side effects · why LDN is usually dosed at bedtime.

The rest of the “regulate immunity” toolkit

LDN is the standout, but it isn’t the only tool in Crista’s third core. Keep these secondary — supporting players around the main lever:

  • Immunoglobulins (oral). Oral colostrum or serum-derived bovine immunoglobulin (SBI) — a concentrated dose of IgG that works in the gut to bind microbial debris and support immune tolerance from the bottom up. A clean, low-risk foundation for the over-reactive child. The full serum-immunoglobulins entry ›
  • Vitamin D. A master immune regulator — the goal is to get the blood level up to target (not just hand over a generic dose), because deficiency leaves the immune system more prone to over-reaction. One of Crista’s named tools in this core.
  • Beta-glucans / medicinal-mushroom modulators. Compounds from mushrooms (and yeast cell walls) that balance immune signaling rather than crank it up or shut it down — immune modulators, the right category for a dysregulated system.
  • Calming the mast-cell / histamine over-reaction. Many of these kids run hot on the mast-cell / histamine axis, which pours fuel on the immune over-reaction. Settling that down is part of regulating immunity. The MCAS entry ›

Choose your path

Start at the top and follow your child. Tap to open.

1 · Is your child’s immune system stuck in over-reaction — flaring, neuroinflamed, autoimmune-flavored?

Yes → you’re in Crista’s “regulate immunity” core, and LDN is the standout tool — it calms inflamed microglia and rebalances the immune tilt. It pairs with, not replaces, clearing the trigger (the “beat the bugs” work).

2 · Is mold part of the picture?

Often yes for these kids. Mold is a major driver of the immune over-reaction Crista’s framework is built around — and you have to remove the exposure and drain before retuning immunity sticks. Start with the mold protocol — the drainage-first ladder — and bring LDN in as the immune-regulation layer.

3 · Ready to consider LDN — what do you need?

A prescriber willing to use LDN and a compounding pharmacy to make the low-dose liquid. Start very low, titrate up slowly over weeks, dose at bedtime, and expect vivid dreams / sleep changes early that usually settle. It’s low-risk and can be stopped — but it’s not a substitute for antibiotics or IVIG when those are indicated.

4 · Want the gentler, secondary immune tools too?

Build the foundation under LDN: oral immunoglobulins (SBI / colostrum), vitamin D to target, beta-glucans / mushroom modulators, and settling the mast-cell / histamine over-reaction. These support the immune retuning; LDN leads it.

This is a lot to sequence — and you don’t have to hold it alone. Minta reads your child’s labs, infection and mold history, and daily symptoms together, tells you whether LDN fits, where it sits against the “beat the bugs” work, what to support it with, and watches the first weeks with you so an early side effect doesn’t get mistaken for a failure. Let Minta walk this with you →

How to vet a practitioner

Credentials, polish, and how conventional an approach sounds tell you little about whether a practitioner will help your child — or harm them. What does: their behavior and their incentives. Watch those.

Red flags

  • Reaches for LDN as a standalone fix — ignoring the infection or mold trigger that’s keeping the immune system over-reacting in the first place.
  • Starts at a full adult dose instead of titrating a child up slowly — or doesn’t warn you that vivid dreams / sleep changes are normal early and usually settle.
  • Presents LDN as a cure, or as a reason to stop antibiotics or skip IVIG when those are genuinely indicated.
  • Can’t name a compounding pharmacy or explain the pediatric titration — a sign they don’t actually use it.
  • Sells you the LDN AND the testing AND the whole supplement stack, all up front (the conflict of interest), and promises it will fix things.

Green flags

  • Treats LDN as one layer of “regulate immunity” — alongside clearing the trigger and opening drainage — not a magic bullet.
  • Starts low and titrates slowly, doses at bedtime, and warns you about early vivid dreams / sleep shifts and how to adjust.
  • Honest about the evidence — calls the PANS use mechanistic-and-reasonable, strong-in-autoimmune, not RCT-proven — and welcomes your other doctors.
  • Keeps LDN compatible with antibiotics / IVIG rather than positioning it against them.

Bottom line

Low-dose naltrexone is a tiny dose of an old opioid-blocker that, at a fraction of its addiction dose, becomes something else entirely: an immune modulator and anti-inflammatory that calms inflamed microglia in the brain and rebalances an over-reactive immune tilt — without suppressing immunity. That makes it a clean fit for Jill Crista’s “regulate immunity” core and for the PANS/mold kid whose immune system is mis-firing at their own brain. The evidence is real in fibromyalgia, Crohn’s, and MS, and well-tolerated in kids — but clinical and emerging in PANS, not RCT-proven. So it’s a reasonable, low-risk, increasingly-used tool to trial — not a cure to count on, and not a replacement for antibiotics or IVIG. The practical shape: a prescription, compounded into a low-dose liquid, started very low and titrated up slowly, usually at bedtime, with vivid dreams the most common early side effect — and it sits alongside the rest of the immune-regulation toolkit (oral immunoglobulins, vitamin D to target, beta-glucans, calming the mast-cell over-reaction). Parent education, not medical advice — bring it to your team as questions.

How Plan B stays honest

Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.

← Back to the Field Guide